Clinical Trials Browser

Phase 2 × OTHER × Interleukin-7 × Clear all

NCT03929107 2019-04-26

Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma.

Phase 2 Unknown

Lymphoma, B-Cell

NCT01368107 2015-02-09

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Lymphopenia